Consent and compliance in chemoprevention trials Journal Article
| Authors: | Dermatis, H.; Rowland, J.; Miransky, J.; Kerner, J.; Osborne, M.; Holland, J. |
| Article Title: | Consent and compliance in chemoprevention trials |
| Abstract: | In determining the efficacy of omega-3 fatty acids, or any other chemoprevention agent in reducing risk for breast cancer, women must be willing to participate in clinical trials and fully adhere to the medication regimen. Little information is known regarding what types of women at risk for breast cancer are likely to participate in such trials and how they will adhere to a long-term chemoprevention regimen. One component of the Breast Cancer Prevention Program at Memorial Sloan-Kettering Cancer Center was designed to investigate psychosocial factors associated with consent and adherence to a chemoprevention regimen. © 1988 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted. |
| Journal Title: | Cancer Investigation |
| Volume: | 6 |
| Issue: | 5 |
| ISSN: | 0735-7907 |
| Publisher: | Informa Healthcare |
| Date Published: | 1988-01-01 |
| Start Page: | 633 |
| End Page: | 635 |
| Language: | English |
| DOI: | 10.3109/07357908809082133 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Export Date: 1 October 2014 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work